References
- Valdez M, Jeronimo J, Bansil P, et al. Effectiveness of novel, lower cost molecular human papillomavirus-based tests for cervical cancer screening in rural China. Int J Cancer. 2016;138(6):1453–1461. doi:10.1002/ijc.29877
- Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.21492
- Ho CM, Lee BH, Chang SF, et al. Integration of human papillomavirus correlates with high level of viral oncogene transcripts in cervical carcinogenesis. Virus Res. 2011;161(2):124–130. doi:10.1016/j.virusres.2011.06.012
- Melsheimer P, Vinkokurova S, Wentzensen N, Bastert G, von Knebel Doeberitz M. DNA aneuploidy and integration of human papillomavirus type 16 e6/e7 oncogenes in intraepithelial neoplasia and invasive squamous cell carcinoma of the cervix uteri. Clin Cancer Res. 2004;10(9):3059–3063. doi:10.1158/1078-0432.CCR-03-0565
- Vinokurova S, Wentzensen N, Kraus I, et al. Type-dependent integration frequency of human papilloma virus genomes in cervical lesions. Cancer Res. 2008;68(1):307–313. doi:10.1158/0008-5472.CAN-07-2754
- Origoni M, Cristoforoni P, Carminati G, et al. E6/E7mRNA testing for human papilloma virus-induced highgrade cervical intraepithelial disease (CIN2/CIN3): a promising perspective. E Cane Med Sci. 2015;9:533.
- Fu ZC, Wang FM, Cai JM. Gene expression changes in residual advanced cervical cancer after radiotherapy: indicators of poor prognosis and radioresistance. Med Sci Monit. 2015;21(2):1276–1287. doi:10.12659/MSM.893689
- Chacko S. Effect of structured teaching programme on VIA test for early detection and diagnosis of cervical cancer. Nurs J India. 2014;105(5):221–224.
- Pan QJ, Hu SY, Zhang X, et al. Pooled analysis of the performance of liquid-based cytology in population-based cervical cancer screening studies in China. Cancer Cytopathol. 2013;121(9):473–482. doi:10.1002/cncy.21297
- Stuebs FA, Schulmeyer CE, Mehlhorn G, et al. Accuracy of colposcopy-directed biopsy in detecting early cervical neoplasia: a retrospective study. Arch Gynecol Obstet. 2019;299(2):525–532. doi:10.1007/s00404-018-4953-8
- Furtado Y, Almeida G, Lima R, et al. Microinvasive squamous carcinoma (FIGO stage IA1) of the cervix: are there colposcopic criteria for the diagnosis? Am J Obstet Gynecol. 2011;205(4):360.e1–360.e4. doi:10.1016/j.ajog.2011.06.036
- Josefsson AM, Magnusson PK, Ylitalo N, et al. Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: a nested case-control study. Lancet. 2000;355(9222):2189–2193. doi:10.1016/S0140-6736(00)02401-6
- Shen G, Cheng J, Wang Y, Zhou P, Viral ZG. DNA load of high-risk human papilloma virus is closely associated with the grade of cervical lesions. Int J Clin Exp Med. 2014;7(12):5826–5831.
- Tsakogiannis D, Kyriakopoulou Z, Ruether IG, et al. Determination of human papillomavirus 16 physical status through E1/E6 and E2/E6 ratio analysis. J Med Microbiol. 2014;63(Pt12):1716–1723. doi:10.1099/jmm.0.076810-0
- Sun C, Reimers LL, Burk RD. Methylation of HPV16 genome CpG sites is associated with cervix precancer and cancer. Gynecol Oncol. 2011;121(1):59–63. doi:10.1016/j.ygyno.2011.01.013
- Moody CA, Laimins LA. Human papilloma virus on coproteins: pathways to transformation. Nat Rev Cancer. 2010;10(8):550–560. doi:10.1038/nrc2886
- Schmitz M, Driesch C, Beer-Grondke K, et al. Loss of gene function as a consequence of human papilloma virus DNA integration. Int J Cancer. 2012;131(5):E593–E602. doi:10.1002/ijc.27433
- Pett M, Coleman N. Integration of high-risk human papillomavirus: a key event in cervical carcinogenesis. J Pathol. 2007;212(4):356–367. doi:10.1002/path.2192
- Huang J, Qian Z, Gong Y, et al. Comprehensive genomic variation profiling of cervical intraepithelial neoplasia and cervical cancer identifies potential targets for cervical cancer early warning. J Med Genet. 2019;56(3):186–194. doi:10.1136/jmedgenet-2018-105745